In 2023, as the COVID-19 pandemic receded, the African Development Bank Group launched the African Pharmaceutical Technology Foundation to address the inequities in vaccine production and distribution during the pandemic that disproportionately affected the African continent. The foundation aims to enhance Africa’s local pharmaceutical capacity and access to the technologies necessary for discovering and manufacturing medicines. This commentary identifies critical concerns that could undermine the foundation’s objectives and legitimacy, including the potential misuse of public resources due to overlap with a similar agency; the endorsement of a “black box” system that impedes genuine international technology transfer of pharmaceutical know-how and resources; a continent-wide approach that fails to account for Africa’s diversity; and the absence of a clear public accountability structure in the foundation’s governance framework. The article also offers preliminary recommendations to address these challenges.
Skip Nav Destination
Article navigation
Commentary|
January 21 2025
The Inequitable Access to Vaccines and Medicines in Africa: A Critical Review of the African Pharmaceutical Technology Foundation (APTF)
Morris K. Odeh
1
Law
, Dalhousie University, Halifax, NS, Canada
Correspondence: [email protected]
Search for other works by this author on:
Correspondence: [email protected]
Global Perspectives (2024) 5 (1): 127997.
Article history
Received:
March 20 2024
Accepted:
October 29 2024
Citation
Morris K. Odeh; The Inequitable Access to Vaccines and Medicines in Africa: A Critical Review of the African Pharmaceutical Technology Foundation (APTF). Global Perspectives 31 January 2024; 5 (1): 127997. doi: https://doi.org/10.1525/gp.2025.127997
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.